Thrombosis and APS: Lessons Learned from Another Black Swan Tale

Area of Science:

• Rheumatology
• Immunology
• Hematology

Background:

• Antiphospholipid syndrome (APS) is a chronic autoimmune disease defined by thrombotic events and/or pregnancy morbidity in the presence of antiphospholipid antibodies (aPL).
• Extra-criteria manifestations of APS, though less common, can significantly impact patient prognosis and may not respond to standard anticoagulant therapy.

Observation:

• A patient with newly diagnosed APS presented with recurrent venous thrombosis and refractory cutaneous ulcerations.
• The skin lesions showed no improvement with standard anticoagulant treatment, suggesting a complex autoimmune component.

Findings:

• The patient received immunomodulatory therapy, including steroid pulses and belimumab, for concurrent thrombotic and microvascular involvement.
• This treatment led to progressive amelioration and complete recovery from the severe clinical manifestations of APS.

Implications:

• Highlights the importance of suspecting APS in young individuals with unprovoked thrombosis and considering aPL testing even during anticoagulant therapy.
• Emphasizes the need for retesting aPL in patients with high titers and underscores that APS, as an autoimmune disease, may require immunomodulatory treatments beyond anticoagulation for optimal outcomes.